Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Thompson

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
NPJ Cardiovascular Health|March 26, 2026
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertensionJuan A Delgado-SanMartin, Merve Keles, Niamh Errington, et al.
Chest|May 15, 2007
Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitudeJ Kenneth Baillie, Matthew G D Bates, A A Roger Thompson, et al.
Radiology|February 6, 2024
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CTKrit Dwivedi, Michael Sharkey, Liam Delaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Interleukin-6 is critical in the development of pulmonary vascular disease in <i>Gcn2-</i>deficient miceMax Schwiening, Qingyue Gao, Mark Southwood, et al.
The European Respiratory Journal|February 29, 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertensionRobert A Lewis, A A Roger Thompson, Catherine G Billings, et al.
Annals of the American Thoracic Society|October 15, 2024
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?Ellis Cerrone, Abdul G Hameed, David G Kiely, et al.
High Altitude Medicine & Biology|December 29, 2012
Retinal vessel tortuosity in response to hypobaric hypoxiaIan J C MacCormick, John Somner, Daniel S Morris, et al.
Frontiers in Medicine|July 7, 2018
Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class ICatherine G Billings, Robert Lewis, Iain J Armstrong, et al.
ERJ Open Research|April 6, 2022
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurinRebecca Dowey, Joby Cole, A A Roger Thompson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2017
Mechanical Activation of Hypoxia-Inducible Factor 1α Drives Endothelial Dysfunction at Atheroprone SitesShuang Feng, Neil Bowden, Maria Fragiadaki, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
NPJ Cardiovascular Health|March 26, 2026
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertensionJuan A Delgado-SanMartin, Merve Keles, Niamh Errington, et al.
Chest|May 15, 2007
Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitudeJ Kenneth Baillie, Matthew G D Bates, A A Roger Thompson, et al.
Radiology|February 6, 2024
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CTKrit Dwivedi, Michael Sharkey, Liam Delaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Interleukin-6 is critical in the development of pulmonary vascular disease in <i>Gcn2-</i>deficient miceMax Schwiening, Qingyue Gao, Mark Southwood, et al.
The European Respiratory Journal|February 29, 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertensionRobert A Lewis, A A Roger Thompson, Catherine G Billings, et al.
Annals of the American Thoracic Society|October 15, 2024
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?Ellis Cerrone, Abdul G Hameed, David G Kiely, et al.
High Altitude Medicine & Biology|December 29, 2012
Retinal vessel tortuosity in response to hypobaric hypoxiaIan J C MacCormick, John Somner, Daniel S Morris, et al.
Frontiers in Medicine|July 7, 2018
Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class ICatherine G Billings, Robert Lewis, Iain J Armstrong, et al.
ERJ Open Research|April 6, 2022
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurinRebecca Dowey, Joby Cole, A A Roger Thompson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2017
Mechanical Activation of Hypoxia-Inducible Factor 1α Drives Endothelial Dysfunction at Atheroprone SitesShuang Feng, Neil Bowden, Maria Fragiadaki, et al.
Pageof 10